Given the limited accuracy of clinically used risk scores such as the Systematic COronary
Risk Evaluation 2 system and the Second Manifestations of ARTerial disease 2 risk scores …

Importance Whether protein risk scores derived from a single plasma sample could be
useful for risk assessment for atherosclerotic cardiovascular disease (ASCVD), in …

Atherosclerosis constitutes a persistent inflammatory ailment, serving as the predominant
underlying condition for coronary artery disease (CAD), peripheral artery disease (PAD) …

Aims In the era of personalized medicine, it is of utmost importance to be able to identify
subjects at the highest cardiovascular (CV) risk. To date, single biomarkers have failed to …

Cardiovascular diseases are the leading causes of mortality worldwide. Among them,
hypertension and its pathological complications pose a major risk for the development of …

Coronary heart disease (CHD) will soon become the leading cause of death and morbidity
in the world. Early detection and treatment of CHD is thus imperative to improve global …

Cardiovascular disease (CVD) is the leading cause of death globally. Risk assessment is
crucial for identifying at-risk individuals who require immediate attention as well as to guide …

Aims Current risk scores do not accurately identify patients at highest risk of recurrent
atherosclerotic cardiovascular disease (ASCVD) in need of more intensive therapeutic …

Atherosclerotic cardiovascular disease (ASCVD) proceeds through a series of stages:
initiation, progression (or regression), and complications. By integrating known biology …

Objective—Incorporation of novel plasma protein biomarkers may improve current models
for prediction of atherosclerotic cardiovascular disease (ASCVD) risk. Approach and Results …